Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Strong Buy
Exponential Moving Average
Strong Buy
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
PepGen Inc. Common Stock (PEPG)
Pharmaceutical Preparations
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
1 MARINA PARK DRIVE, SUITE 900
BOSTON, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
05/06/2022
Market Cap
303,410,135
Shares Outstanding
23,810,000
Weighted SO
23,813,547
Total Employees
N/A
Upcoming Earnings
N/A
Beta
1.7360
Last Div
0.0000
Range
3.72-19.298
Chg
0.2400
Avg Vol
163801
Mkt Cap
303410135
Exch
NASDAQ
Country
US
Phone
781-797-0979
DCF Diff
6.8154
DCF
2.5496
Div Yield
0.0000
P/S
182.7772
EV Multiple
-2.7179
P/FV
1.9497
Div Yield %
0.0000
P/E
-3.3912
PEG
0.2530
Payout
0.0000
Current Ratio
7.4537
Quick Ratio
7.4537
Cash Ratio
2.9893
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
1949.9413
CCC
-1949.9413
Gross Margin
0.1271
Op Margin
-57.7193
Pretax Margin
-53.6548
Net Margin
-53.6988
Eff Tax Rate
0.0132
ROA
-0.4606
ROE
-0.6274
ROCE
-0.5590
NI/EBT
1.0008
EBT/EBIT
0.9296
EBIT/Rev
-57.7193
Debt Ratio
0.1003
D/E
0.1252
LT Debt/Cap
0.0955
Total Debt/Cap
0.1113
Int Coverage
-50.4550
CF/Debt
-3.8525
Equity Multi
1.2481
Rec Turnover
0.0000
Pay Turnover
0.1872
Inv Turnover
0.0000
FA Turnover
0.0620
Asset Turnover
0.0086
OCF/Share
-2.3033
FCF/Share
-2.3184
Cash/Share
4.9680
OCF/Sales
-45.0512
FCF/OCF
1.0066
CF Coverage
-3.8525
ST Coverage
-24.5277
CapEx Coverage
-151.6937
Div&CapEx Cov
-151.6937
P/BV
1.9497
P/B
1.9497
P/S
182.7772
P/E
-3.3912
P/FCF
-4.0305
P/OCF
-4.0421
P/CF
-4.0421
PEG
0.2530
P/S
182.7772
EV Multiple
-2.7179
P/FV
1.9497
DPS
0.0000